| Akums Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544222 |
NSE Symbol : AKUMS |
P/E(TTM) : 90.01 |
|
ISIN Demat : INE09XN01023 |
Div & Yield% : 0.44 |
EPS(TTM) : 7.40 |
|
Book Value(₹) : 154.29 |
Market Cap(₹Cr) : 10,483.23 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,348.74 | 1,311.78 | 1,444.12 | 1,286.83 | 1,162.06 |
| Other Income | 112.97 | 124.19 | 94.12 | 96.15 | 58.48 |
| Stock Adjustments | 3.26 | 10.05 | -6.44 | 3.06 | 18.45 |
| Total Income | 1,464.97 | 1,446.02 | 1,531.80 | 1,386.04 | 1,238.99 |
| EXPENDITURE : | |||||
| Raw Materials | 830.34 | 811.06 | 867.24 | 791.21 | 786.51 |
| Power and Fuel Cost | 49.64 | 45.36 | 42.40 | 42.04 | 36.25 |
| Other Manufacturing Expenses | 68.15 | 68.18 | 62.69 | 42.04 | 62.62 |
| Selling and Administration Expenses | 42.19 | 25.73 | 31.90 | 22.33 | 16.82 |
| Miscellaneous Expenses | 52.73 | 31.27 | 404.21 | 147.63 | 503.99 |
| Employee Benefit Expenses | 217.99 | 201.74 | 175.28 | 147.30 | 136.37 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 203.91 | 262.69 | -51.93 | 193.50 | -303.56 |
| Interest | 10.04 | 15.31 | 18.31 | 13.18 | 3.65 |
| Gross Profit | 193.87 | 247.38 | -70.24 | 180.32 | -307.21 |
| Depreciation | 45.50 | 39.55 | 32.69 | 30.00 | 27.76 |
| Profit Before Tax | 148.37 | 207.83 | -102.93 | 150.32 | -334.97 |
| Current Tax | 36.40 | 49.66 | 62.52 | 41.00 | 0.34 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.32 | -2.83 | 0.00 | -16.11 | 46.46 |
| Reported Net Profit | 111.64 | 161.00 | -165.45 | 125.43 | -381.78 |
| Extraordinary Items | -4.88 | 2.61 | -7.98 | -105.11 | 0.99 |
| Adjusted Net Profit | 116.52 | 158.39 | -157.47 | 230.54 | -382.77 |
| Adjustment below Net Profit | 0.47 | 861.44 | -2.18 | 0.00 | -11.62 |
| Profit/Loss Balance carried down | 1,317.83 | 295.39 | 463.02 | 351.36 | 744.75 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 13.77 | 0.00 |
| P & L Balance carried down | 1,429.93 | 1,317.83 | 295.39 | 463.02 | 351.36 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 150.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 3.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 7.29 | 10.52 | -11.56 | 8.77 | -53.37 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 158.56 | 150.57 | 10.06 | 21.77 | 25.94 |
| Book Value(Adj)-Unit Curr | 158.56 | 150.57 | - | - | - |
